GSFPX
Price
$15.55
Change
+$0.24 (+1.57%)
Updated
Apr 23 closing price
Net Assets
3.13B
GSPAX
Price
$15.61
Change
+$0.24 (+1.56%)
Updated
Apr 23 closing price
Net Assets
3.13B
Ad is loading...

GSFPX vs GSPAX

Header iconGSFPX vs GSPAX Comparison
Open Charts GSFPX vs GSPAXBanner chart's image
Goldman Sachs US Eq Div and Premium P
Price$15.55
Change+$0.24 (+1.57%)
VolumeN/A
Net Assets3.13B
Goldman Sachs US Eq Div and Premium A
Price$15.61
Change+$0.24 (+1.56%)
VolumeN/A
Net Assets3.13B
GSFPX vs GSPAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSFPX vs. GSPAX commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSFPX is a Buy and GSPAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GSFPX (3.13B) and GSPAX (3.13B) have equal amount of cash in the bank . GSFPX pays higher dividends than GSPAX: GSFPX (1.27) vs GSPAX (0.95). GSFPX was incepted earlier than GSPAX: GSFPX (7 years) vs GSPAX (20 years). GSPAX (1.12) is less costly to investors than GSFPX (0.75). GSFPX (30.00) and GSPAX (30.00) have comparable annual turnover. GSFPX has a lower initial minimum investment than GSPAX: GSFPX (0) vs GSPAX (1000). GSFPX annual gain was more profitable for investors over the last year : -0.32 vs. GSPAX (-0.64). GSFPX (39.55) and GSPAX (37.72) have equivalent 5 years return.
GSFPXGSPAXGSFPX / GSPAX
Total Expense Ratio0.671.0067%
Annual Report Gross Expense Ratio0.751.1267%
Fund Existence7 years20 years-
Gain YTD-9.592-9.73099%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.13B3.13B100%
Annual Yield % from dividends1.270.95134%
Returns for 1 year-0.32-0.6450%
Returns for 3 years6.025.01120%
Returns for 5 years39.5537.72105%
Returns for 10 yearsN/A41.00-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BAFGX15.39N/A
N/A
Brown Advisory Growth Equity Inst
EREMX14.34N/A
N/A
Parametric Emerging Markets R6
RYBKX81.24N/A
N/A
Rydex Banking A
ACMVX14.93N/A
N/A
American Century Mid Cap Value Inv
TCMVX15.25N/A
N/A
Nuveen Mid Cap Value A